Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Thyroid Neoplasms 2 Breast Neoplasms, Male 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Nodule 1 Thyroid Diseases 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcoma 1 Prostatic Diseases 1 Parotid Gland Neoplasms 1 Pancreatic Neoplasms 1 Overweight 1 Obesity 1 Neoplasms by Site 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Histiocytoma, Malignant Fibrous 1 Head and Neck Neoplasms 1 Genital Neoplasms, Male 1

Interventions

pembrolizumab 24 Nivolumab 23 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 sonidegib 4 encorafenib 4 Photochemotherapy 4 Mohs Surgery 4 HhAntag691 4 Educational Status 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Biopsy, Needle × Clear all

NCT00715793 2017-10-03

UPCI-07-008

University of Pittsburgh

Phase 1/2 Completed

39 enrolled 12 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡